arrow
J

Jonathon R. Campbell

centre for outcomes research and evaluation
H指数:31
被引数:4,143

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety of tuberculosis preventive treatment among people receiving or about to initiate immunosuppressive medications: a systematic review and meta-analysis

结核病预防性治疗在接受或即将开始免疫抑制药物的人群中的安全性:一项系统评价和荟萃分析

2026-09-210
OAAI
Minimal supply chain and forecasting testing volumes for clinical bacteriology laboratories in resource-limited settings for individual patient care: a costing study

资源受限环境下个体化患者护理的临床细菌学实验室最小供应链和预测检测量:一项成本研究

2026-08-010
OA
Estimated impact of timely, guideline-adherent tuberculosis screening in primary care settings among new permanent residents to British Columbia, Canada: A population-based study

及时、符合指南的结核病筛查在加拿大不列颠哥伦比亚省新永久居民初级保健设置中的估计影响:一项基于人群的研究

2026-04-130
OAAI
The effectiveness, cost-effectiveness, budget impact, and return on investment of scaling up tuberculosis screening and preventive treatment in Brazil, Georgia, Kenya, and South Africa: a modelling study

扩大巴西、格鲁吉亚、肯尼亚和南非的结核病筛查和预防性治疗的有效性、成本效益、预算影响和投资回报:一项模型研究

2025-10-150
OAAI
Costs of 4 Months of Rifampin Versus 2 Months of Double-dose Rifampin for Tuberculosis Infection: Post-Hoc Analysis of a Phase 2b Randomized Trial

4个月利福平与2个月双倍剂量利福平治疗结核感染的成本比较:一项2b期随机试验的事后分析

2025-09-010
OAAI
Non-inferiority stepped wedge cluster randomized controlled trial on all-oral shorter regimens for rifampicin resistant/multidrug-resistant TB in Pakistan - a study protocol

在巴基斯坦进行的利福平耐药/多药耐药结核病的口服短程方案非劣效性阶梯楔形集群随机对照试验——一项研究方案

2025-05-070
OA
Predicting Risk of Tuberculosis (TB) Disease in People Who Migrate to a Low-TB Incidence Country: Development and Validation of a Multivariable, Dynamic Risk-Prediction Model Using Health Administrative Data
2024-11-202
OA